Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment.
about
PET/CT imaging of c-Myc transgenic mice identifies the genotoxic N-nitroso-diethylamine as carcinogen in a short-term cancer bioassayAnimal models used in identifying gender-related differences.The Trp53 hemizygous mouse in pharmaceutical development: points to consider for pathologists.The use of genetically modified mice in cancer risk assessment: challenges and limitations.Risk assessment in the genomic era.Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.Historical perspective on the use of animal bioassays to predict carcinogenicity: evolution in design and recognition of utility.Twenty-six-Week carcinogenicity study of chloroform in CB6F1 rasH2-transgenic mice.Genetic interaction between the unstable v-Ha-RAS transgene (Tg.AC) and the murine Werner syndrome gene: transgene instability and tumorigenesis.Animal models for the study of childhood leukemia: considerations for model identification and optimization to identify potential risk factors.Interlaboratory comparison of short-term carcinogenicity studies using CB6F1-rasH2 transgenic mice.Mutation and overexpression of the transgene in ethylnitrosourea-induced tumors in mice carrying a human prototype c-Ha-ras gene.Scientific Opinion on the use of Resorcinol as a food additiveReduction in the number of animals and the evaluation period for the positive control group in Tg.rasH2 short-term carcinogenicity studies.An integrative test strategy for cancer hazard identification.
P2860
Q27309893-E38F049A-A550-44A4-B1F1-5042A17629C5Q34327912-F0C463CB-3D93-4C9F-B326-3D690D2C2EA8Q34560247-D576DEB7-F53D-4071-BB75-287DFA34AD12Q35688431-538A49C3-A67F-4C49-A7A4-B5F916408DEBQ35812472-053B3BA6-F83E-45AC-AB2E-CE1B5367E2A5Q36980449-6F60BB71-EA2E-468F-BFA0-84CDB41FF332Q37857848-52F5EA30-21FE-44BE-A000-41A6066A901EQ44018759-58BAF30C-29B9-44CA-9F52-3D373FFB0D18Q44145923-17417A71-08B0-4747-9595-E94B17A7C048Q44152063-51D574E9-2D7E-455C-94EE-88EA3FE6F3B1Q44404169-C6A1C117-CD71-4A98-9795-F7D8B1E78CAAQ44704085-7A610D1F-D566-4475-80E8-BE8DF5BEC734Q47147812-9A252C7F-AEC2-4581-9F06-21E5247CC85DQ48130096-DC60F5EC-41CB-48A7-8371-7EF3AFD4FEB0Q50856445-F9CDCFD3-8E2D-4573-9C38-6A6916B196C0
P2860
Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Use of transgenic animals for ...... lications for risk assessment.
@ast
Use of transgenic animals for ...... lications for risk assessment.
@en
type
label
Use of transgenic animals for ...... lications for risk assessment.
@ast
Use of transgenic animals for ...... lications for risk assessment.
@en
prefLabel
Use of transgenic animals for ...... lications for risk assessment.
@ast
Use of transgenic animals for ...... lications for risk assessment.
@en
P2093
P2860
P1476
Use of transgenic animals for ...... lications for risk assessment.
@en
P2093
C B McCullough
D A Neumann
D Gulezian
D Jacobson-Kram
D Robinson
P2860
P304
P356
10.1177/019262330002800320
P407
P577
2000-05-01T00:00:00Z